0000950144-05-011369 Sample Contracts

KOS AND JERINI SIGN EXCLUSIVE COLLABORATION AND LICENSE AGREEMENT FOR DEVELOPMENT, MARKETING AND DISTRIBUTION OF ICATIBANT IN THE UNITED STATES AND CANADA
For Immediate Release • November 8th, 2005 • Kos Pharmaceuticals Inc • Pharmaceutical preparations

• Icatibant, in final Phase III clinical trials for hereditary angioedema (HAE), represents next potential new product launch for both companies scheduled for the first half of 2007

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.